Abvc Biopharma Stock Net Income
| ABVC Stock | USD 2.35 0.16 7.31% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess ABVC Biopharma's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -4.7 M | -5 M | |
| Net Loss | -4.7 M | -5 M | |
| Net Loss | -14.8 M | -14 M | |
| Net Loss | (0.38) | (0.40) | |
| Net Income Per E B T | 1.05 | 1.08 |
ABVC | Net Income | Build AI portfolio with ABVC Stock |
ABVC Biopharma Company Net Income Analysis
ABVC Biopharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ABVC Biopharma Net Income | (5.26 M) |
Most of ABVC Biopharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABVC Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ABVC Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for ABVC Biopharma is extremely important. It helps to project a fair market value of ABVC Stock properly, considering its historical fundamentals such as Net Income. Since ABVC Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ABVC Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ABVC Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
ABVC Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, ABVC Biopharma reported net income of (5.26 Million). This is 101.54% lower than that of the Biotechnology sector and 107.51% lower than that of the Health Care industry. The net income for all United States stocks is 100.92% higher than that of the company.
ABVC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABVC Biopharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ABVC Biopharma could also be used in its relative valuation, which is a method of valuing ABVC Biopharma by comparing valuation metrics of similar companies.ABVC Biopharma is currently under evaluation in net income category among its peers.
ABVC Biopharma ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ABVC Biopharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ABVC Biopharma's managers, analysts, and investors.Environmental | Governance | Social |
ABVC Biopharma Institutional Holders
Institutional Holdings refers to the ownership stake in ABVC Biopharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ABVC Biopharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ABVC Biopharma's value.| Shares | Honkamp Krueger Financial Services Inc | 2025-03-31 | 0.0 | Virtu Financial Llc | 2025-03-31 | 0.0 | Two Sigma Securities, Llc | 2025-06-30 | 0.0 | Vanguard Group Inc | 2025-06-30 | 111.5 K | Geode Capital Management, Llc | 2025-06-30 | 110.5 K | Xtx Topco Ltd | 2025-06-30 | 52.6 K | Renaissance Technologies Corp | 2025-06-30 | 41.7 K | Northern Trust Corp | 2025-06-30 | 37.1 K | State Street Corp | 2025-06-30 | 12.9 K | Sbi Securities Co Ltd | 2025-06-30 | 483 | Tower Research Capital Llc | 2025-06-30 | 354 |
ABVC Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (1.47) % | ||||
| Current Valuation | 56.78 M | ||||
| Shares Outstanding | 24.3 M | ||||
| Shares Owned By Insiders | 11.36 % | ||||
| Shares Owned By Institutions | 3.23 % | ||||
| Number Of Shares Shorted | 365.78 K | ||||
| Price To Book | 4.62 X | ||||
| Price To Sales | 69.13 X | ||||
| Revenue | 509.59 K | ||||
| Gross Profit | 797.92 K | ||||
| EBITDA | (4.34 M) | ||||
| Net Income | (5.26 M) | ||||
| Cash And Equivalents | 2.99 M | ||||
| Cash Per Share | 0.09 X | ||||
| Total Debt | 3.2 M | ||||
| Debt To Equity | 0.34 % | ||||
| Current Ratio | 2.68 X | ||||
| Book Value Per Share | 0.51 X | ||||
| Cash Flow From Operations | (1.81 M) | ||||
| Short Ratio | 5.34 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 2.02 | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 55.16 M | ||||
| Total Asset | 7.54 M | ||||
| Retained Earnings | (68.95 M) | ||||
| Working Capital | (4.38 M) | ||||
| Net Asset | 7.54 M |
About ABVC Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ABVC Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABVC Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABVC Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out ABVC Biopharma Piotroski F Score and ABVC Biopharma Altman Z Score analysis. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth 1.045 | Return On Assets | Return On Equity |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.